Instil Bio, Inc.
NASDAQ:TIL
66.1 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0.138 | 0 |
| Cost of Revenue
| 4.756 | 5.987 | 2.752 | 0 | 0.02 |
| Gross Profit
| -4.756 | -5.987 | -2.752 | 0.138 | -0.02 |
| Gross Profit Ratio
| 0 | 0 | 0 | 1 | 0 |
| Reseach & Development Expenses
| 42.988 | 141.056 | 107.251 | 19.399 | 4.027 |
| General & Administrative Expenses
| 47.553 | 62.235 | 48.309 | 14.383 | 2.558 |
| Selling & Marketing Expenses
| -4.756 | 0 | 0 | 0 | 0 |
| SG&A
| 42.797 | 62.235 | 48.309 | 14.383 | 2.558 |
| Other Expenses
| 72.012 | -0.564 | -1.195 | -4.656 | -0.005 |
| Operating Expenses
| 85.785 | 203.291 | 155.56 | 33.782 | 6.585 |
| Operating Income
| -90.541 | -226.458 | -155.56 | -33.644 | -6.585 |
| Operating Income Ratio
| 0 | 0 | 0 | -243.797 | 0 |
| Total Other Income Expenses Net
| -65.546 | 1.208 | -1.195 | -3.943 | 0.063 |
| Income Before Tax
| -156.087 | -225.25 | -156.755 | -37.587 | -6.522 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -272.37 | 0 |
| Income Tax Expense
| 0 | -2.073 | 0.039 | 0.151 | -0.068 |
| Net Income
| -156.087 | -223.177 | -156.794 | -37.738 | -6.454 |
| Net Income Ratio
| 0 | 0 | 0 | -273.464 | 0 |
| EPS
| -24 | -34.46 | -24.3 | -5.89 | -1.01 |
| EPS Diluted
| -24 | -34.46 | -24.3 | -5.89 | -1.01 |
| EBITDA
| -85.785 | -200.2 | -155.56 | -34.031 | -6.565 |
| EBITDA Ratio
| 0 | 0 | 0 | -246.601 | 0 |